Stay updated on ICT-107 Immunotherapy in GBM Clinical Trial
Sign up to get notified when there's something new on the ICT-107 Immunotherapy in GBM Clinical Trial page.

Latest updates to the ICT-107 Immunotherapy in GBM Clinical Trial page
- Check4 days agoNo Change Detected
- Check11 days agoChange DetectedThe page shows an updated ClinicalTrials.gov software revision indicator, changing the displayed build from v3.5.2 to v3.5.3.SummaryDifference0.0%

- Check18 days agoChange DetectedRevision updated from v3.5.0 to v3.5.2.SummaryDifference0.0%

- Check26 days agoNo Change Detected
- Check47 days agoChange DetectedThe page revision is updated from v3.4.3 to v3.5.0, reflecting a minor version update.SummaryDifference0.0%

- Check54 days agoChange DetectedRevision updated from v3.4.2 to v3.4.3.SummaryDifference0.0%

- Check83 days agoChange DetectedRevision: v3.4.2 was added. The older Revision: v3.4.1 notice and the funding-status alert were removed.SummaryDifference0.4%

- Check90 days agoChange DetectedAdded a site-wide notice about potential delays due to a lapse in government funding and updated the page revision to v3.4.1 (replacing v3.4.0).SummaryDifference0.4%

Stay in the know with updates to ICT-107 Immunotherapy in GBM Clinical Trial
Enter your email address, and we'll notify you when there's something new on the ICT-107 Immunotherapy in GBM Clinical Trial page.